Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

V.C. Di Maio, V. Cento, I. Lenci, M. Aragri, P. Rossi, S. Barbaliscia, M. Melis, G. Verucchi, C.F. Magni, E. Teti, A. Bertoli, F. Antonucci, M.C. Bellocchi, V. Micheli, C. Masetti, S. Landonio, S. Francioso, F. Santopaolo, A.M. Pellicelli, V. CalvarusoL. Gianserra, M. Siciliano, D. Romagnoli, R. Cozzolongo, G. Brancaccio, C.F. Perno, A. Grimaldi, V. Pisani, A. De Maria, L.A. Nicolini, C. Viscoli, A. Aghemo, S. Bruno, M. Cerrone, M. Colombo, M.L. Russo, M. Bertolotti, A. Mazzola, F. Sozio, L. Carioti, M. Ciotti, C. D'Ambrosio, D. Di Paolo, C. Furlan, P. Gallo, A. Gasbarrini, M. Milana, M. Romano, A. Mangia, M.S. Mura

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)514-528
Number of pages15
JournalLiver International
Volume37
Issue number4
DOIs
Publication statusPublished - 2017

Cite this